In a surprise move Monday, Marathon Pharmaceuticals told patient advocates that it would “pause” the launch of its drug Emflaza because of pricing concerns expressed by patients and advocacy groups.

The number of Californians newly signed up for health insurance through Covered California, the state’s insurance marketplace created under the Affordable Care Act, dropped 3 percent compared with last year, according to enrollment figures released by Covered California on Monday.

Provider choice is down. Premiums and cost sharing are up. This is the current state of the healthcare market, Janet Trautwein, executive vice president and CEO of NAHU, on Wednesday told Congress — and it’s unsustainable, she said.

President Trump said Sunday that it could take “sometime into next year” until his ObamaCare replacement plan is ready, a slower timetable than he and other Republicans have put forward in the past.

Two of the top Republicans in Congress on Monday said they are pushing ahead with the plan to begin repealing ObamaCare this spring, despite any confusion caused by President Trump saying the process could spill into next year.

A California lawmaker has introduced a bill that would ban drugmakers from issuing coupons that lower patients’ prescription copayments for certain drugs. The bill by Assembly member Jim Wood, D-Healdsburg, would prohibit distribution of discount coupons for prescription drugs where a cheaper, FDA-approved equivalent exists.